Search
Theravance Biopharma Inc
TBPHAdd to Watchlist
16.860USD
+0.010+0.06%
Close 07-31 16:00（ET）Quotes delayed by 15 min
873.82MMarket Cap
7.39P/E TTM
TBPH Financials
See Theravance Biopharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Theravance Biopharma Inc Earnings Date
Latest Release
May 7, 2026
EPS / Forecast
-0.10/-0.14
Revenue / Forecast
17.70M/17.20M
Period
FY2025 Earnings
Revenue(YoY)
107.46M
66.92%
EPS(YoY)
2.10
282.21%
Analyst Rating
HOLD
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its total revenue reached 107.46M, with a year-on-year change of 64.38M.
What are the current assets of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its current assets were 418.46M, with a year-on-year change of 159.80.
What are the total assets of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its total assets of Theravance Biopharma Inc were 485.57M, with a year-on-year change of 37.10.
What are the total liabilities of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its total liabilities of Theravance Biopharma Inc were 188.85M, with a year-on-year change of 5.73.
What is the total equity of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its total equity of Theravance Biopharma Inc was 296.72M, with a year-on-year change of 69.03.
What is the net operating income of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its net operating income of Theravance Biopharma Inc was -3.60M, with a year-on-year change of 91.51.
What is the net investment of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its net investment of Theravance Biopharma Inc was -105.28M, with a year-on-year change of -957.08.
What is the net financing of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its net financing of Theravance Biopharma Inc was -3.25M, with a year-on-year change of -30.08.
What is the Earnings Per Share (EPS) of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 2.10, with a year-on-year change of 282.21.
What is the net income of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its net income was 105.89M, with a year-on-year change of 287.70.
What is the net margin of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its net profit margin was 98.54, with a year-on-year change of 212.45.
What is the debt-to-asset ratio of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its debt-to-asset ratio was 6.75, with a year-on-year change of -21.15.
What is the Return on Equity (ROE) of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its Return on Equity (ROE) was 44.85, with a year-on-year change of 254.42.
What is the Return on Assets (ROA) of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its Return on Assets (ROA) was 25.22, with a year-on-year change of 264.55.
What is the operating profit of Theravance Biopharma Inc?
According to Theravance Biopharma Inc's FY2025 earnings report, its operating profit was -3.60M, with a year-on-year change of 91.51.